All
Childhood Pneumonia May Be Associated With Cancer Risk
February 2nd 2018While causes for pneumonia were varied – including bacteria (14 percent), virus (22 percent) and unspecified (64 percent) – the majority of children did not have immune deficiencies recorded at the time of their pneumonia diagnosis.
We Can. I Can. How One Innovator Is Working to Bring HOPE to Pediatric Patients With Cancer
February 2nd 2018The children’s app is paired with a complementary parent and caregiver-focused platform and guide that helps drive conversations about disease and treatment, timed to the child’s progression and in language that aligns with the game.
Joe Biden Says Toxic Burn Pits May Have Contributed to His Son's Cancer
February 2nd 2018For years, former Vice President Joe Biden’s son, Beau, was stationed near large, potentially toxic burn pits. After Beau died of glioblastoma (GBM) in May 2015, Joe Biden grew skeptical and started to question if the burn pits contributed to his son’s cancer diagnosis.
Trump Urges for Congress to Pass Right To Try Bill
February 1st 2018After patients have exhausted all therapeutic options in their cancer treatment, oftentimes there is nowhere left for them to turn. Despite a terminal diagnosis, some patients may have more options in their remaining days if one bill is passed – if only it were that easy.
Adding Tecentriq to Chemo Regimen Improves Lung Cancer Outcomes
January 31st 2018Not all patients with non-small cell lung cancer (NSCLC) respond to immunotherapy, so researchers are exploring the use of combination regimens, including immune checkpoint inhibitors and chemotherapy, to improve outcomes in these patients.
Patients Concerned as Humana Takes Herceptin Off Preferred Drug List in South Florida
January 30th 2018Until recently, Herceptin, which is used to treat patients with metastatic breast cancer, was fully covered under Humana’s South Florida Medicare Advantage plans. But, after taking it off the preferred drug list, patients will now be responsible for 20 percent of the drug’s cost, better aligning South Florida’s plans with Humana’s other Medicare Advantage plans.
Exploring Unanswered Questions on CAR-T Cell Therapy in Myeloma
January 29th 2018The success of CAR- (chimeric antigen receptor) T cell therapy is causing landmark change in the way that patients with multiple myeloma are being treated, but more research needs to be done to better understand the role that these agents will play.
Exploring Clonal Evolution in Colorectal Cancer
January 27th 2018Patients with microsatellite instability-high (MSI-H) colorectal cancer may undergo a distinct pattern of clonal evolution, which in turn, would impact the use of targeted and immunologic therapies in these patients, according to study results presented at the 2018 Gastrointestinal Cancer Symposium.